Locatelli F, Kang HJ, Bruno B, Gandemer V, et al. Ruxolitinib for pediatric patients with treatment-naive and steroid-refractory acute graft-versus-host disease (REACH4). Blood 2024 Jul 24:blood.2023022565. doi: 10.1182/blood.2023022565.
PMID: 39046767